Solid Tumor Malignancies
Oncology
2
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
DS
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
2029
2030
2031
Daiichi SankyoValemetostat Tosylate
Vir BiotechnologyVIR-5525
Eli Lilly and CompanyExpert Review
Clinical Trials (3)
Total enrollment: 1,400 patients across 3 trials
Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
Start: Feb 2026Est. completion: Feb 2032900 patients
Phase 2Not Yet Recruiting
Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Start: Jul 2025Est. completion: Aug 2029
Phase 1Recruiting
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Start: Jun 2025Est. completion: Jun 2028500 patients
N/ARecruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
2h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
2h ago
Office Administrator
SystImmune
2h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
3h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
3h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
3h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 1,400 patients
3 companies competing in this space